HomeARTV • NASDAQ
add
Artiva Biotherapeutics Inc
Previous close
$6.18
Day range
$6.15 - $6.46
Year range
$1.47 - $7.75
Market cap
159.42M USD
Avg Volume
176.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.93M | 20.06% |
Net income | -20.77M | -29.06% |
Net profit margin | — | — |
Earnings per share | -0.84 | — |
EBITDA | -21.27M | -20.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 108.01M | -41.75% |
Total assets | 130.94M | -37.52% |
Total liabilities | 20.97M | -8.59% |
Total equity | 109.97M | — |
Shares outstanding | 24.72M | — |
Price to book | 1.36 | — |
Return on assets | -39.19% | — |
Return on capital | -41.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.77M | -29.06% |
Cash from operations | -14.73M | -0.52% |
Cash from investing | 16.04M | 1,760.46% |
Cash from financing | -121.00K | -303.33% |
Net change in cash | 1.19M | 107.62% |
Free cash flow | -7.89M | 12.26% |
About
Founded
2019
Website
Employees
104
